Výsledky vyhledávání - "Organoplatinum Compounds/adverse effects"

Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study

Autoři: Seium, Y. Stupp, R. Ruhstaller, T. a další

Témata: Adult Aged Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use Camptothecin/adverse effects/analogs & derivatives/therapeutic use Colorectal Neoplasms/*drug therapy/*mortality/pathology Dose-Response Relationship, Drug Drug Administration Schedule Female Fluorouracil/adverse effects/therapeutic use Humans Leucovorin/adverse effects/therapeutic use Liver Neoplasms/drug therapy/*secondary Lung Neoplasms/drug therapy/*secondary Male Maximum Tolerated Dose Middle Aged Neoplasm Metastasis Neoplasm Staging Organoplatinum Compounds/adverse effects/therapeutic use *Palliative Care Prognosis Survival Analysis Treatment Outcome

Popis souboru: application/pdf

Relation: Annals of Oncology; https://iris.unil.ch/handle/iris/90162; serval:BIB_2C2ACD8CD0E9; 000229102200013

Dostupnost: https://iris.unil.ch/handle/iris/90162
https://doi.org/10.1093/annonc/mdi154

Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.

Autoři: Fokkema, E. Groen, H.J. Bauer, J. a další

Témata: Aged, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Carcinoma, Small Cell/blood, Small Cell/drug therapy, Female, Humans, Lung Neoplasms/blood, Lung Neoplasms/drug therapy, Male, Middle Aged, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Platinum/blood, Treatment Outcome

Relation: Journal of Clinical Oncology; https://iris.unil.ch/handle/iris/45107; serval:BIB_13228; 000084043300016

Dostupnost: https://iris.unil.ch/handle/iris/45107

Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.

Autoři: Proietti, S. De Baere, T. Bessoud, B. a další

Témata: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Duodenal Ulcer/chemically induced, Duodenal Ulcer/therapy, Duodenum/blood supply, Embolization, Therapeutic, Endoscopy, Gastrointestinal, Female, Femoral Artery, Humans, Infusions, Intra-Arterial, Liver Neoplasms/drug therapy, Liver Neoplasms/secondary, Male, Middle Aged, Mitomycin/administration & dosage, Mitomycin/adverse effects, Nitrosourea Compounds/administration & dosage, Nitrosourea Compounds/adverse effects, Organophosphorus Compounds/administration & dosage, Organophosphorus Compounds/adverse effects, Organoplatinum Compounds/administration & dosage, Organoplatinum Compounds/adverse effects, Stomach/blood supply, Stomach Ulcer/chemically induced

Popis souboru: application/pdf

Relation: European Radiology; https://iris.unil.ch/handle/iris/245242; serval:BIB_F092E9D60282; 000247969800028

Dostupnost: https://iris.unil.ch/handle/iris/245242
https://doi.org/10.1007/s00330-006-0552-3

Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.

Autoři: Hubert, C. Lucidi, V. Weerts, J. a další

Témata: Adult, Aged, 80 and over, Antineoplastic Agents/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Belgium/epidemiology, Bevacizumab/administration & dosage, Biological Products/administration & dosage, Chemical and Drug Induced Liver Injury/epidemiology, Chemical and Drug Induced Liver Injury/etiology, Colorectal Neoplasms/drug therapy, Colorectal Neoplasms/pathology, Colorectal Neoplasms/surgery, Female, Fluorouracil/adverse effects, Hepatic Veno-Occlusive Disease/chemically induced, Hepatic Veno-Occlusive Disease/epidemiology, Humans, Leucovorin/adverse effects, Liver Neoplasms/drug therapy, Liver Neoplasms/secondary, Liver Neoplasms/surgery, Male, Middle Aged, Organoplatinum Compounds/adverse effects, Postoperative Complications/etiology, Prevalence, Biological agents, CALI, Colorectal liver metastases

Relation: European Journal of Surgical Oncology; https://iris.unil.ch/handle/iris/234134; serval:BIB_FC017328C71D; 000447578100011

Dostupnost: https://iris.unil.ch/handle/iris/234134
https://doi.org/10.1016/j.ejso.2018.07.050

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.

Autoři: Giannone, G. Scotto, G. Katsaros, D. a další

Témata: BRCA1 Protein/genetics, BRCA2 Protein/genetics, Drug Hypersensitivity/genetics, Female, Genes, BRCA1, BRCA2, Germ-Line Mutation, Humans, Multicenter Studies as Topic, Observational Studies as Topic, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Retrospective Studies, BRCA, Hypersensitivity reactions, Ovarian cancer, Platinum salts

Relation: Gynecologic oncology; https://iris.unil.ch/handle/iris/228823; serval:BIB_BD3BE28C9923; 000664094500013

Dostupnost: https://iris.unil.ch/handle/iris/228823
https://doi.org/10.1016/j.ygyno.2021.04.018

The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases: uracil plasma ratio in patients with colorectal liver metastases

Autoři: Maarten J. Deenen Bart A. W. Jacobs Niels de Vries a další

Přispěvatelé: Maarten J. Deenen Bart A. W. Jacobs Niels de Vries a další

Zdroj: European Journal of Clinical Pharmacology. 74:737-744

Témata: Male, 0301 basic medicine, Antimetabolites, Antineoplastic, Organoplatinum Compounds, Antimetabolites, Clinical Trial, Phase III, Observational Study, Bevacizumab/adverse effects, Antineoplastic/adverse effects, 03 medical and health sciences, 0302 clinical medicine, Taverne, Antineoplastic Combined Chemotherapy Protocols, Journal Article, 80 and over, Humans, Pharmacology (medical), Organoplatinum Compounds/adverse effects, Uracil, Colorectal Neoplasms/blood, Capecitabine, Aged, Pharmacology, Aged, 80 and over, Uracil/analogs & derivatives, Liver/surgery, Liver Neoplasms/blood, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Liver Neoplasms, Capecitabine/adverse effects, Middle Aged, Antimetabolites, Antineoplastic/adverse effects, 3. Good health, Multicenter Study, Bevacizumab, Oxaliplatin, Liver, Female, Colorectal Neoplasms

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/29430582
https://europepmc.org/abstract/MED/29430582
https://core.ac.uk/display/160115079
https://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F376779
http://dspace.library.uu.nl/handle/1874/366129
https://pubmed.ncbi.nlm.nih.gov/29430582/
https://link.springer.com/article/10.1007/s00228-018-2426-4
https://dspace.library.uu.nl/handle/1874/366129
https://dspace.library.uu.nl/handle/1874/376779

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT): a placebo-controlled randomised phase II study (PLIANT)

Autoři: Glimelius, Bengt Manojlovic, Nebojsa Pfeiffer, Per a další

Zdroj: Glimelius, B, Manojlovic, N, Pfeiffer, P, Mosidze, B, Kurteva, G, Karlberg, M, Mahalingam, D, Buhl Jensen, P, Kowalski, J, Bengtson, M, Nittve, M & Näsström, J 2018, ' Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx(®)) : a placebo-controlled randomised phase II study (PLIANT) ', Acta Oncologica, vol. 57, no. 3, pp. 393-402 . https://doi.org/10.1080/0284186X.2017.1398836

Témata: Adult, Male, Organoplatinum Compounds, Peripheral Nervous System Diseases/chemically induced, Leucovorin, Antineoplastic Agents, Kaplan-Meier Estimate, Fluorouracil/adverse effects, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Antineoplastic Combined Chemotherapy Protocols, Humans, Organoplatinum Compounds/adverse effects, Edetic Acid/analogs & derivatives, Edetic Acid, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Peripheral Nervous System Diseases, Colorectal Neoplasms/drug therapy, Antineoplastic Agents/adverse effects, Middle Aged, Leucovorin/adverse effects, 3. Good health, Oxaliplatin, Pyridoxal Phosphate, Female, Fluorouracil, Pyridoxal Phosphate/analogs & derivatives, Colorectal Neoplasms

Přístupová URL adresa: https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1398836?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/29140155
https://www.scholars.northwestern.edu/en/publications/persistent-prevention-of-oxaliplatin-induced-peripheral-neuropath
https://portal.findresearcher.sdu.dk/da/publications/persistent-prevention-of-oxaliplatin-induced-peripheral-neuropath
https://www.ncbi.nlm.nih.gov/pubmed/29140155
https://scholars.uthscsa.edu/en/publications/persistent-prevention-of-oxaliplatin-induced-peripheral-neuropath
https://uthscsa.influuent.utsystem.edu/en/publications/persistent-prevention-of-oxaliplatin-induced-peripheral-neuropath
https://europepmc.org/article/MED/29140155
https://portal.findresearcher.sdu.dk/da/publications/5cdde1e0-23d6-41c3-831c-bda7004ef6f9
https://portal.findresearcher.sdu.dk/da/publications/5cdde1e0-23d6-41c3-831c-bda7004ef6f9
https://doi.org/10.1080/0284186X.2017.1398836

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Autoři: Yu-Jin Kwon Won Kyu Kim Mi Jang a další

Přispěvatelé: Yu-Jin Kwon Won Kyu Kim Mi Jang a další

Zdroj: Oncotarget

Témata: Male, 0301 basic medicine, Substances, Organoplatinum Compounds, diagnosis, Supplementary concept, Leucovorin, Fluorouracil/adverse effects, Organoplatinum Compounds/therapeutic use, Colorectal Neoplasms/mortality, Antineoplastic Combined Chemotherapy Protocols, Cluster Analysis, Adjuvant, Colorectal, 0303 health sciences, Tumor, Leucovorin/therapeutic use, Colorectal Neoplasms/drug therapy, Middle Aged, Prognosis, Leucovorin/adverse effects, 3. Good health, Treatment Outcome, colon cancer, Chemotherapy, Adjuvant, Female, consensus molecular subtype, Fluorouracil, Colorectal Neoplasms, Research Paper, Adult, mRNA expression-based molecular classification, Fluorouracil/therapeutic use, 03 medical and health sciences, Folfox protocol, Biomarkers, Tumor, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Gene Expression Profiling, DNA microarray, Computational Biology, molecular subtype, Colorectal Neoplasms/genetics, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Transcriptome, Biomarkers

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/28455965
https://www.europepmc.org/articles/PMC5503619/
https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/160269/1/T201701925.pdf
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160269
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
https://www.oncotarget.com/fulltext/17023

A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach

Autoři: Kang Bd Minkyu Jung Hye Jung Park a další

Přispěvatelé: Kang Bd Minkyu Jung Hye Jung Park a další

Zdroj: Journal of Investigational Allergology and Clinical Immunology. 26:168-176

Témata: Adult, Hypersensitivity, Immediate, Male, Organoplatinum Compounds, Immediate/chemically induced, Antineoplastic Agents, Desensitization, Middle Aged, 3. Good health, Drug Hypersensitivity, Oxaliplatin, Skin test, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents/adverse effects, Drug Hypersensitivity/etiology, Hypersensitivity, Chemotherapy, Humans, Female, Cisplatin, Organoplatinum Compounds/adverse effects, Platinum, Skin Tests

Přístupová URL adresa: http://www.jiaci.org/revistas/vol26issue3_4.pdf
https://pubmed.ncbi.nlm.nih.gov/27326984
http://www.jiaci.org/revistas/vol26issue3_4.pdf
https://pesquisa.bvsalud.org/portal/resource/es/ibc-153641
https://www.ncbi.nlm.nih.gov/pubmed/27326984
http://www.jiaci.org/summary/vol26-issue3-num1364
https://europepmc.org/article/MED/27326984
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152118

A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis

Autoři: Nam Kyu Kim Young Suk Park Minkyu Jung a další

Přispěvatelé: Nam Kyu Kim Young Suk Park Minkyu Jung a další

Zdroj: Radiotherapy and Oncology. 118:369-374

Témata: Male, 0301 basic medicine, Organoplatinum Compounds, Adenocarcinoma/surgery, Leucovorin, Fluorouracil/adverse effects, Liver Neoplasms/secondary, Metastasis, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Adjuvant/adverse effects, Adjuvant/methods, Rectal cancer, Dose Fractionation, Adenocarcinoma/pathology, Neoadjuvant Therapy/adverse effects, Liver Neoplasms, Liver Neoplasms/therapy, Chemoradiotherapy, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Leucovorin/adverse effects, Neoadjuvant Therapy, 3. Good health, Fluorouracil/administration & dosage, Treatment Outcome, Rectal Neoplasms/surgery, Leucovorin/administration & dosage, Female, Fluorouracil, Rectal Neoplasms/therapy, Adult, Adenocarcinoma, Disease-Free Survival, Liver Neoplasms/surgery, 03 medical and health sciences, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/administration & dosage, Short-course radiotherapy, Aged, Neoplasm Staging, Rectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoadjuvant Therapy/methods, Chemoradiotherapy, Adjuvant, Liver Neoplasms/pathology, Survival Analysis, Adenocarcinoma/therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Rectal Neoplasms/pathology, Dose Fractionation, Radiation, Neoplasm Grading, Adenocarcinoma/secondary

Popis souboru: 369~374

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/26705682
http://www.sciencedirect.com/science/article/pii/S0167814015006490
https://yonsei.pure.elsevier.com/en/publications/a-phase-ii-study-of-preoperative-mfolfox6-with-short-course-radio
https://ir.ymlib.yonsei.ac.kr/handle/22282913/146639
http://www.ncbi.nlm.nih.gov/pubmed/26705682
https://pubmed.ncbi.nlm.nih.gov/26705682/

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin

Autoři: Julian Hamfjord Janne B. Kjersem G Indrebø a další

Zdroj: Kjersem, J B, Thomsen, M, Guren, T, Hamfjord, J, Carlsson, G, Gustavsson, B, Ikdahl, T, Indrebø, G, Pfeiffer, P, Lingjærde, O, Tveit, K M, Wettergren, Y & Kure, E H 2016, ' AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin ', The Pharmacogenomics Journal, vol. 16, no. 3, pp. 272-279 . https://doi.org/10.1038/tpj.2015.54

Témata: Adult, Male, Time Factors, Genotype, Organoplatinum Compounds, Pharmacogenomic Variants, Fluorouracil/adverse effects, Scandinavian and Nordic Countries, Polymorphism, Single Nucleotide, Disease-Free Survival, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Transaminases/genetics, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Clinical Trials, Organoplatinum Compounds/adverse effects, Polymorphism, Neoplasm Metastasis, Genetic Association Studies, Randomized Controlled Trials as Topic, Retrospective Studies, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Colorectal Neoplasms/drug therapy, Single Nucleotide, Xeroderma Pigmentosum Group D Protein/genetics, Middle Aged, Multidrug Resistance-Associated Protein 2, 3. Good health, Phase III as Topic, Oxaliplatin, Treatment Outcome, Phenotype, Clinical Trials, Phase III as Topic, Pharmacogenomic Variants/genetics, Tumor/genetics, Female, Fluorouracil, Biomarkers, Tumor/genetics, Colorectal Neoplasms, Biomarkers

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/26261061
https://pubmed.ncbi.nlm.nih.gov/26261061/
https://nature.com/articles/tpj201554
https://www.ncbi.nlm.nih.gov/pubmed/26261061
http://palgrave.nature.com/tpj/journal/v16/n3/full/tpj201554a.html
https://mdanderson.elsevierpure.com/en/publications/agxt-and-ercc2-polymorphisms-are-associated-with-clinical-outcome
http://europepmc.org/abstract/MED/26261061
https://portal.findresearcher.sdu.dk/da/publications/5202c7fc-1d45-4ad2-9d4d-aea63205b6f9

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer

Autoři: Hye Lim Jang Ho Yeong Lim Young Suk Park a další

Přispěvatelé: Hye Lim Jang Ho Yeong Lim Young Suk Park a další

Zdroj: Transl Oncol
Translational Oncology, Vol 8, Iss 1, Pp 40-46 (2015)
TRANSLATIONAL ONCOLOGY(8): 1

Témata: Male, 0301 basic medicine, Deoxycytidine/analogs & derivatives, Cancer Research, Gallbladder Neoplasms/drug therapy, Biliary Tract Neoplasms/epidemiology, Cholangiocarcinoma/pathology, Quinazolines/adverse effects, Biliary Tract Neoplasms/pathology, Disease-Free Survival, Article, Erlotinib Hydrochloride, Quinazolines/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Gallbladder Neoplasms/pathology, Humans, Organoplatinum Compounds/adverse effects, Neoplasm Metastasis, Organoplatinum Compounds/administration & dosage, Deoxycytidine/administration & dosage, RC254-282, Aged, Neoplasm Staging, Deoxycytidine/adverse effects, Gallbladder Neoplasms/epidemiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cholangiocarcinoma/epidemiology, Middle Aged, Biliary Tract Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Quinazolines/administration & dosage, 3. Good health, Oncology, Cholangiocarcinoma/drug therapy, Disease Progression, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Deoxycytidine/therapeutic use

Popis souboru: 40~46

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25749176
https://doaj.org/article/6e68cdfd223a4dd3b92bede36ed829c6
http://open-repository.kisti.re.kr/cube/handle/open_repository/481967.do
https://mdanderson.elsevierpure.com/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141497
https://www.sciencedirect.com/science/article/pii/S1936523314001375
https://mdanderson.influuent.utsystem.edu/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
http://europepmc.org/articles/PMC4350637
https://pubmed.ncbi.nlm.nih.gov/25749176/

The impact of liver resection on the dihydrouracil: uracil plasma ratio in patients with colorectal liver metastases

Autoři: Jacobs, Bart A W Snoeren, Nikol Samim, Morsal a další

Přispěvatelé: Jacobs, Bart A W Snoeren, Nikol Samim, Morsal a další

Témata: Aged, 80 and over, Antimetabolites, Antineoplastic/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Bevacizumab/adverse effects, Capecitabine/adverse effects, Colorectal Neoplasms/blood, Female, Humans, Liver/surgery, Liver Neoplasms/blood, Male, Middle Aged, Organoplatinum Compounds/adverse effects, Oxaliplatin, Uracil/analogs & derivatives, Taverne

Popis souboru: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/376779

Dostupnost: https://dspace.library.uu.nl/handle/1874/376779

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Autoři: Sook Ryun Park Yunni Lim Wansik Yu a další

Přispěvatelé: Sook Ryun Park Yunni Lim Wansik Yu a další

Zdroj: The Lancet Oncology. 15:1389-1396

Témata: Male, 0301 basic medicine, Deoxycytidine/analogs & derivatives, Drug-Related Side Effects and Adverse Reactions, Organoplatinum Compounds, Fluorouracil/adverse effects, Deoxycytidine, Drug-Related Side Effects and Adverse Reactions/pathology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Adjuvant/adverse effects, Organoplatinum Compounds/adverse effects, 10. No inequality, Deoxycytidine/administration & dosage, Stomach Neoplasms/drug therapy, Capecitabine, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Deoxycytidine/adverse effects, Stomach Neoplasms/pathology, Middle Aged, 3. Good health, Oxaliplatin, Fluorouracil/analogs & derivatives, Stomach Neoplasms/surgery, Fluorouracil/administration & dosage, Chemotherapy, Adjuvant, Female, Organoplatinum Compounds/administration & dosage, Fluorouracil, Follow-Up Studies

Popis souboru: 1389~1396

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/25439693
https://pubmed.ncbi.nlm.nih.gov/25439693/
http://repository.ajou.ac.kr/handle/201003/12549
https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470204514704735.pdf
http://ir.yu.ac.kr/handle/YU.REPOSITORY/30448?mode=full
https://europepmc.org/article/MED/25439693
https://yonsei.pure.elsevier.com/en/publications/adjuvant-capecitabine-plus-oxaliplatin-for-gastric-cancer-after-d

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Autoři: Taieb J Tabernero J Mini E a další

Přispěvatelé: Taieb J Tabernero J Mini E a další

Zdroj: The Lancet Oncology. 15:862-873

Témata: Male, 0301 basic medicine, Leucovorin -- adverse effects -- therapeutic use, Colonic Neoplasms -- drug therapy -- genetics -- pathology -- surgery, Medizin, Leucovorin, Cetuximab, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, 0302 clinical medicine, ras Proteins -- genetics, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Infusions, Intravenous, Adjuvant, Exons, Sciences bio-médicales et agricoles, Intravenous -- adverse effects, Middle Aged, Intention to Treat Analysis, 3. Good health, [SDV] Life Sciences [q-bio], Drug Eruptions -- etiology, colon cancer, Chemotherapy, Adjuvant, Colonic Neoplasms, Female, Drug Eruptions, Fluorouracil, Fluorouracil -- adverse effects -- therapeutic use, Proto-Oncogene Proteins -- genetics, Adult, Diarrhea, Infusions, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Antibodies, Disease-Free Survival, 03 medical and health sciences, Mucositis -- chemically induced, Chemotherapy, Humans, Exons -- genetics, Organoplatinum Compounds -- adverse effects -- therapeutic use, Neoplasm Staging, Aged, Adenocarcinoma -- drug therapy -- genetics -- pathology -- surgery, CETUXIMAB, oxaliplatinum, 5-FLUOROURACIL, LEUCOVORIN, COLON CANCER, Humanized -- administration & dosage -- adverse effects, 13. Climate action, FOLFOX4, Diarrhea -- chemically induced

Popis souboru: application/pdf; 1 full-text file(s): application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/24928083
https://univ-lyon1.hal.science/hal-02045524v1
https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(14)70227-X.pdf
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)70227-X/fulltext
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02045524
https://boa.unimib.it/handle/10281/260524
https://www.abcsg.com/wp/wp-content/uploads/2014/08/Petacc-8.ABCSG-C05.pdf
https://iris.unito.it/handle/2318/156262
https://hdl.handle.net/2158/940168
https://doi.org/10.1016/S1470-2045(14)70227-X
https://www.ncbi.nlm.nih.gov/pubmed/24928083
https://doi.org/10.1016/S1470-2045(14)70227-X

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer

Autoři: Jeeyun Lee Sang Joon Shin Ik Joo Chung a další

Přispěvatelé: Jeeyun Lee Sang Joon Shin Ik Joo Chung a další

Zdroj: Investigational New Drugs. 32:561-568

Témata: Male, Indoles, Organoplatinum Compounds, Becaplermin, 0302 clinical medicine, Oxonic Acid/administration & dosage, Antineoplastic Combined Chemotherapy Protocols, L-Lactate Dehydrogenase/blood, Colorectal Neoplasms/blood, 2. Zero hunger, Colorectal Neoplasms/drug therapy, Indoles/administration & dosage, Middle Aged, 3. Good health, Interleukin-8/blood, Oxaliplatin, Drug Combinations, C-Reactive Protein, Proto-Oncogene Proteins c-sis/blood, Platelet-Derived Growth Factor/metabolism, Indoles/adverse effects, Vascular Cell Adhesion Molecule-1/blood, Oxonic Acid/adverse effects, Female, Propionates/administration & dosage, Colorectal Neoplasms, Adult, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Disease-Free Survival, 03 medical and health sciences, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/administration & dosage, Aged, Propionates/adverse effects, L-Lactate Dehydrogenase, Interleukin-6, Antineoplastic Combined Chemotherapy Protocols/adverse effects, C-Reactive Protein/metabolism, Vascular Endothelial Growth Factor A/blood, TSU-68, Interleukin-8, Tegafur/adverse effects, Tegafur/administration & dosage, Colorectal cancer, Oxindoles, Oxonic Acid, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Interleukin-6/blood

Popis souboru: 561~568

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/24573743
https://rd.springer.com/article/10.1007/s10637-014-0075-8
https://koreauniv.pure.elsevier.com/en/publications/a-phase-ii-open-label-randomized-multicenter-trial-of-tsu-68-in-c
https://www.ncbi.nlm.nih.gov/pubmed/24573743
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/36028
https://yonsei.pure.elsevier.com/en/publications/a-phase-ii-open-label-randomized-multicenter-trial-of-tsu-68-in-c
https://link.springer.com/content/pdf/10.1007%2Fs10637-014-0075-8.pdf
https://ascopubs.org/doi/abs/10.1200/jco.2013.31.4_suppl.492

Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis

Autoři: Urdzik, Jozef Bjerner, Tomas Wanders, Alkwin a další

Zdroj: HPB. 15(4):265-272

Témata: Aged, Antineoplastic Agents/*adverse effects/therapeutic use, Blood Flow Velocity, Chemotherapy, Adjuvant, Colorectal Neoplasms/*drug therapy/pathology/physiopathology, Dilatation, Pathologic/etiology, Female, Humans, Liver Neoplasms/*drug therapy/physiopathology/secondary, *Magnetic Resonance Imaging, Male, Middle Aged, Organoplatinum Compounds/*adverse effects/therapeutic use, Portal Vein/*drug effects/pathology, Predictive Value of Tests, Prospective Studies, Sensitivity and Specificity

Popis souboru: print

Přístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-110933

Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis

Autoři: Jae Kyung Rho Jin Soo Kim Nam Kyu Kim a další

Přispěvatelé: Jae Kyung Rho Jin Soo Kim Nam Kyu Kim a další

Zdroj: Oncology. 81:175-183

Témata: Adult, Male, Organoplatinum Compounds, Leucovorin, Kaplan-Meier Estimate, Colorectal neoplasms, Disease-Free Survival, 03 medical and health sciences, Colorectal Neoplasms/secondary, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/administration & dosage, Neoplasm Metastasis, Liver metastasis, Adjuvant, Aged, Retrospective Studies, Colorectal Neoplasms/pathology, Liver Neoplasms/surgery, Colorectal Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Liver Neoplasms, Colorectal Neoplasms/surgery, Liver Neoplasms/pathology, Middle Aged, Prognosis, Adjuvant chemotherapy, 3. Good health, Survival Rate, Oxaliplatin, Liver Neoplasms/drug therapy, Fluorouracil/administration & dosage, Chemotherapy, Adjuvant, Leucovorin/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Fluorouracil, Colorectal Neoplasms, Follow-Up Studies

Popis souboru: 175~183

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/22057187
https://yonsei.pure.elsevier.com/en/publications/efficacy-of-oxaliplatin-based-chemotherapy-in-curatively-resected
https://www.karger.com/Article/Purchase/333440
https://pubmed.ncbi.nlm.nih.gov/22057187/
https://mdanderson.elsevierpure.com/en/publications/efficacy-of-oxaliplatin-based-chemotherapy-in-curatively-resected
https://www.ncbi.nlm.nih.gov/pubmed/22057187

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial

Autoři: Byeong Bae Park Dae Ho Lee Young Yiul Lee a další

Přispěvatelé: Byeong Bae Park Dae Ho Lee Young Yiul Lee a další

Zdroj: Investigational New Drugs. 29:154-160

Témata: Dexamethasone/administration & dosage, Adult, Male, Deoxycytidine/analogs & derivatives, Lymphoma, Organoplatinum Compounds, Salvage therapy, Antineoplastic Agents, Ifosfamide/therapeutic use, Salvage Therapy, Deoxycytidine, Dexamethasone, Disease-Free Survival, Dexamethasone/therapeutic use, Non-Hodgkin/pathology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Organoplatinum Compounds/adverse effects, Ifosfamide, Organoplatinum Compounds/administration & dosage, Deoxycytidine/administration & dosage, Aged, B-Lymphocytes, Deoxycytidine/adverse effects, Dexamethasone/adverse effects, Lymphoma, Non-Hodgkin, Antineoplastic Agents/therapeutic use, Antineoplastic Agents/adverse effects, Non-Hodgkin/drug therapy, Ifosfamide/adverse effects, Middle Aged, Organoplatinum Compounds/therapeutic use, Ifosfamide/administration & dosage, Gemcitabine, Antineoplastic Agents/administration & dosage, 3. Good health, B-Lymphocytes/pathology, Oxaliplatin, Treatment Outcome, Non-Hodgkin's lymphoma, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Deoxycytidine/therapeutic use

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/19756371
https://link.springer.com/content/pdf/10.1007%2Fs10637-009-9320-y.pdf
https://link.springer.com/article/10.1007/s10637-009-9320-y/fulltext.html
https://mdanderson.elsevierpure.com/en/publications/salvage-therapy-with-gemcitabine-ifosfamide-dexamethasone-and-oxa
http://www.ncbi.nlm.nih.gov/pubmed/19756371
https://pubmed.ncbi.nlm.nih.gov/19756371/
https://link.springer.com/article/10.1007/s10637-009-9320-y

Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome

Autoři: Schiffer, Eduardo Frossard, Jean-Louis Rubbia-Brandt, Laura a další

Zdroj: Journal of Surgical Oncology, Vol. 99, No 7 (2009) pp. 439-446
Journal of surgical oncology

Témata: Organoplatinum Compounds, Hepatic Veno-Occlusive Disease, Antineoplastic Agents, ddc:616.07, 616.07, ddc:616.0757, Rats, Sprague-Dawley, 03 medical and health sciences, 0302 clinical medicine, Animals, Hepatectomy, Organoplatinum Compounds/adverse effects, ddc:616, Monocrotaline, ddc:617, 616.0757, Hepatic Veno-Occlusive Disease/chemically induced/*physiopathology/surgery, Colorectal Neoplasms/drug therapy, Antineoplastic Agents/*adverse effects, Liver Regeneration, Rats, 3. Good health, Oxaliplatin, Disease Models, Animal, Colorectal Neoplasms

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/19353590
https://onlinelibrary.wiley.com/doi/10.1002/jso.21276
https://core.ac.uk/display/60825822
https://archive-ouverte.unige.ch/unige:20079
http://europepmc.org/abstract/MED/19353590
https://pubmed.ncbi.nlm.nih.gov/19353590/
https://archive-ouverte.unige.ch/unige:20079